Evaluation of Human Leukocyte Antigen Class I and Class II in End-Stage Renal Disease Occurrence in Indonesian Transplantation Patients

Table 4

Association of three-locus haplotypes with ESRD.

	ESRD		Control		value	OR	OR 95%CI
	n	%	n	%
A02-B15-DRB112	33	5.98	7	1.01	0.001	5.724	2.512–13.050
A24-B35-DRB112	7	1.27	34	5.34	0.001	0.227	0.100–0.518
A24-B35-DRB115	1	0.18	9	1.41	0.036	0.126	0.016–1.003
A24-B13-DRB115	7	1.27	1	0.15	0.043	8.171	1.002–66.610

HLA: human leukocyte antigen; ESRD: end-stage renal disease.